44th week of 2020 patent applcation highlights part 10 |
Patent application number | Title | Published |
20200338101 | PREPARATION METHOD FOR VARIOUS NOVEL FUCOSYL OLIGOSACCHARIDES AND USE THEREOF | 2020-10-29 |
20200338102 | CATECHOLAMINE PRODRUGS FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE | 2020-10-29 |
20200338103 | HUMAN MILK OLIGOSACCHARIDES FOR MODULATING INFLAMMATION | 2020-10-29 |
20200338104 | USE OF CHLOROGENIC ACID IN PREPARATION OF DRUG FOR TREATING CHORDOMA | 2020-10-29 |
20200338105 | PHARMACEUTICAL COMPOSITIONS FOR DEMODEX RELATED BLEPHARITIS AND EYELID CRUSTING | 2020-10-29 |
20200338106 | Methods and Substances for Prevention and Treatment of Neurodegenerative Diseases | 2020-10-29 |
20200338107 | USE OF CARRIMYCIN OR ACTIVE INGREDIENTS THEREOF AND USE THEREOF | 2020-10-29 |
20200338108 | METHODS FOR TREATING HEPATITIS B INFECTION | 2020-10-29 |
20200338109 | METHODS FOR TREATING HEPATITIS B INFECTION | 2020-10-29 |
20200338110 | REDUCING BETA-CATENIN AND IDO EXPRESSION TO POTENTIATE IMMUNOTHERAPY | 2020-10-29 |
20200338111 | METHOD FOR ENHANCING RECOVERY OF COSMETIC LASER-TREATED SKIN | 2020-10-29 |
20200338112 | METHODS AND MATERIALS FOR TREATING CANCER | 2020-10-29 |
20200338113 | AGENT FOR IMPROVING OCULAR SUBJECTIVE SYMPTOMS AND METHOD THEREOF | 2020-10-29 |
20200338114 | PHARMACEUTICAL COMPOSITIONS AND METHODS RELATING TO INHIBITING FIBROUS ADHESIONS OR INFLAMMATORY DISEASE USING LOW SULPHATE FUCANS | 2020-10-29 |
20200338116 | MODIFIED IMMUNE-MODULATING PARTICLES | 2020-10-29 |
20200338117 | METHOD AND SYSTEM FOR PROVIDING PERITONEAL DIALYSIS FLUIDS WITH VARIABLE POTASSIUM CONCENTRATIONS | 2020-10-29 |
20200338118 | SYSTEM FOR OPTIMAL HYDRATION | 2020-10-29 |
20200338119 | HYPERTONIC PHARMACEUTICAL COMPOSITIONS CONTAINING AN ANTI-PLATINUM CHEMOPROTECTANT AGENT | 2020-10-29 |
20200338120 | INTRADIALYTIC USE OF SODIUM THIOSULFATE | 2020-10-29 |
20200338121 | CARBON DIOXIDE SLOW-RELEASE PACK FOR SKIN AND METHOD OF SLOWLY RELEASING CARBON DIOXIDE TO SKIN | 2020-10-29 |
20200338122 | SPINEL FERRITE IMPREGNATED MESOPOROUS SILICA CONTAINING A PLATINUM COMPLEX | 2020-10-29 |
20200338123 | METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS | 2020-10-29 |
20200338124 | CELL | 2020-10-29 |
20200338125 | METHOD FOR EXPANSION OF LYMPHOCYTES | 2020-10-29 |
20200338126 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS | 2020-10-29 |
20200338127 | Th1 vaccination priming for active immunotherapy | 2020-10-29 |
20200338128 | PRECISION MOLECULAR ADAPTOR SYSTEM FOR CAR-T IMMUNOTHERAPY | 2020-10-29 |
20200338129 | COMPOSITIONS INCLUDING ENUCLEATED ERYTHROID CELLS | 2020-10-29 |
20200338130 | GENETICALLY ENGINEERED HEMATOPOIETIC STEM CELLS AND USES THEREOF | 2020-10-29 |
20200338131 | Method | 2020-10-29 |
20200338132 | COMPOSITIONS AND METHODS FOR THE EXPANSION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS AND TREATMENT OF INHERITED METABOLIC DISORDERS | 2020-10-29 |
20200338133 | STIMULATION OF ANGIOGENESIS BY FIBROBLAST DERIVED EXOSOMES | 2020-10-29 |
20200338134 | MUSCLE TREATMENT METHOD USING MYOD MUTANT | 2020-10-29 |
20200338135 | LIPOCALIN-TYPE PROSTAGLANDIN D2 SYNTHASE PRODUCTION PROMOTING AGENT | 2020-10-29 |
20200338136 | COMPOSITION FOR IMPROVING, PREVENTING OR TREATING SKIN DISEASES COMPRISING INDUCED PLURIPOTENT STEM CELL-DERIVED MESENCHYMAL STEM CELL AND EXOSOME DERIVED THEREFROM | 2020-10-29 |
20200338137 | PROBIOTIC BIOFILM SUPPOSITORIES | 2020-10-29 |
20200338138 | USE OF CORIOBACTERIIA TO PROMOTE GUT HEALTH | 2020-10-29 |
20200338139 | COMPOSITIONS FOR MICROBIAL ANTI-ADHESION | 2020-10-29 |
20200338140 | Composition for Preventing or Improving Impaired Renal Function, Pharmaceutical Composition, Food/Beverage Composition, and Method of Preventing or Improving Impaired Renal Function Using the Composition for Preventing or Improving Impaired Renal Function | 2020-10-29 |
20200338141 | Composition for Reducing Blood Uric Acid Level and Composition for Preventing or Improving Hyperuricemia, Pharmaceutical Composition, Food/Beverage Composition, Method for Reducing Blood Uric Acid Level, and Method of Preventing or Improving Hyperuricemia | 2020-10-29 |
20200338142 | FOOD COMPOSITION AND PHARMACEUTICAL COMPOSITION USED FOR INCREASING EXERCISE PERFORMANCE AND AMELIORATING FATIGUE | 2020-10-29 |
20200338143 | AGENT FOR PREVENTING OR TREATING SMALL INTESTINAL INJURY INDUCED BY SPECIFIC NSAID AND PPI | 2020-10-29 |
20200338144 | AGENT FOR PREVENTING OR TREATING SMALL INTESTINAL INJURY INDUCED BY NON-STEROIDAL ANTI-INFLAMMATORY DRUG AND PROTON PUMP INHIBITOR | 2020-10-29 |
20200338145 | METHOD OF IMPROVING UROGENITAL HEALTH USING PROBIOTIC BACTERIA | 2020-10-29 |
20200338146 | VARIANT AAV CAPSIDS FOR INTRAVITREAL DELIVERY | 2020-10-29 |
20200338147 | COMPOSITIONS AND METHODS OF TREATMENT OF EHLERS-DANLOS SYNDROMES | 2020-10-29 |
20200338148 | GENE THERAPIES FOR LYSOSOMAL DISORDERS | 2020-10-29 |
20200338149 | NOVEL GENETICALLY ENGINEERED VACCINIA VIRUSES | 2020-10-29 |
20200338150 | ENCAPSULATED CANNABINOID FORMULATIONS FOR ORAL DELIVERY | 2020-10-29 |
20200338151 | ENCAPSULATED CANNABINOID FORMULATIONS FOR TRANSDERMAL DELIVERY | 2020-10-29 |
20200338152 | SUBCUTANEOUS INJECTION FORMULATION FOR REDUCING BODY WEIGHT AND USES THEREOF | 2020-10-29 |
20200338153 | ANAEROBIC ANTIOXIDANT COMPOSITION | 2020-10-29 |
20200338154 | COMPOSITIONS AND METHODS FOR INVASIVE AND NON-INVASIVE PROCEDURAL SKINCARE | 2020-10-29 |
20200338155 | METHODS OF TREATING CHRONIC DISORDERS WITH COMPLEMENT INHIBITORS | 2020-10-29 |
20200338156 | COMPOSITION COMPRISING CHP (CYCLO-HIS PRO) FOR PREVENTING, IMPROVING OR TREATING OF BONE LOSS RELATED DISEASE | 2020-10-29 |
20200338157 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS | 2020-10-29 |
20200338158 | Therapeutic Drug for Non-Alcoholic Fatty Liver Disease | 2020-10-29 |
20200338159 | COMPOSITION COMPRISING AN ALGAL PROTEOGLYCAN EXTRACT AND USE THEREOF | 2020-10-29 |
20200338160 | METHODS AND COMPOSITIONS FOR REGENERATING HAIR CELLS AND/OR SUPPORTING CELLS | 2020-10-29 |
20200338161 | BTNL9 AND ERMAP AS NOVEL INHIBITORS OF THE IMMUNE SYSTEM FOR IMMUNOTHERAPIES | 2020-10-29 |
20200338162 | EFFECT OF HEMOPEXIN THERAPY AFTER INTRACEREBRAL HEMORRHAGE | 2020-10-29 |
20200338163 | COMPOSITIONS AND METHODS FOR CARDIAC TISSUE REPAIR | 2020-10-29 |
20200338164 | VEGFR-FC FUSION PROTEIN FORMULATIONS | 2020-10-29 |
20200338165 | THERAPEUTIC DOSING OF A NEUREGULIN OR A FRAGMENT THEREOF FOR TREATMENT OR PROPHYLAXIS OF HEART FAILURE | 2020-10-29 |
20200338166 | ANTI-TUMOR DRUG COMPOSITION AND POLYNUCLEOTIDE COMPOSITION | 2020-10-29 |
20200338167 | METHODS AND COMPOSITIONS FOR MANAGEMENT OF GASTROINTESTINAL DISORDERS | 2020-10-29 |
20200338168 | METHODS OF TREATING INFLAMMATORY SKIN DISORDERS | 2020-10-29 |
20200338169 | METHODS OF TREATING INFLAMMATORY SKIN DISORDERS | 2020-10-29 |
20200338170 | METHODS OF TREATING INFLAMMATORY SKIN DISORDERS | 2020-10-29 |
20200338171 | PHARMACEUTICAL COMBINATION FOR IMPROVING GLYCEMIC CONTROL AS ADD-ON THERAPY TO BASAL INSULIN | 2020-10-29 |
20200338172 | FUNCTIONALIZED MICROBUBBLE EMBODIMENTS FOR ULTRASOUND-MEDIATED TREATMENT AND METHODS OF MAKING AND USING THE SAME | 2020-10-29 |
20200338173 | DEAD ANTIGEN STIMULATED IMMATURE HETEROGENOUS DENDRITIC CELLS AS THERAPEUTICS FOR DISEASES | 2020-10-29 |
20200338174 | METHODS FOR ACTIVATING IMMUNE CELLS | 2020-10-29 |
20200338175 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PANCREATIC CANCER AND OTHER CANCERS | 2020-10-29 |
20200338176 | METHODS AND COMPOSITIONS RELATING TO P62 FOR THE TREATMENT AND PROPHYLAXIS OF CANCER | 2020-10-29 |
20200338177 | CHIMERIC ANTIGEN RECEPTORS THAT BIND TO SSEA4 AND USES THEREOF | 2020-10-29 |
20200338178 | MALARIAL VACCINATION METHODS AND REGIMENS | 2020-10-29 |
20200338179 | IMMUNOGENIC CONJUGATES AND METHODS OF USE THEREOF | 2020-10-29 |
20200338180 | Vaccines Comprising Mycobacterium Leprae Polypeptides for the Prevention, Treatment, and Diagnosis of Leprosy | 2020-10-29 |
20200338181 | IMMUNOGENIC TREATMENT OF CANCER | 2020-10-29 |
20200338182 | Intranasal delivery of a cyclic-di-nucleotide adjuvanted vaccine for tuberculosis | 2020-10-29 |
20200338183 | RAPID AND PROLONGED IMMUNOGIC THERAPEUTIC | 2020-10-29 |
20200338184 | RAPID AND PROLONGED IMMUNOGIC THERAPEUTIC | 2020-10-29 |
20200338185 | OSTRICH ANTIBODY FOR BACTERIAL INFECTIOUS DISEASES | 2020-10-29 |
20200338186 | FELINE CALICIVIRUS VACCINE | 2020-10-29 |
20200338187 | PCV/MYCOPLASMA HYOPNEUMONIAE VACCINE | 2020-10-29 |
20200338188 | IMMUNIZATIONS OF AVIANS BY ADMINISTRATION OF NON-REPLICATING VECTORED VACCINES | 2020-10-29 |
20200338189 | Immunogenic sequences from a Phage Tail Length Tape Measure Protein, bacteria expressing the same and their use in treating a cancer | 2020-10-29 |
20200338190 | HUMAN CYTOMEGALOVIRUS VACCINE | 2020-10-29 |
20200338191 | FUCOIDAN-QUATERNIZED CHITOSAN NANOPARTICLES AND APPLICATION THEREOF | 2020-10-29 |
20200338192 | TREATMENT AND PREVENTION OF ALZHEIMER'S DISEASE (AD) | 2020-10-29 |
20200338193 | METHOD OF TREATING A LOCALIZED FIBROTIC DISORDER USING AN IL-33 ANTAGONIST | 2020-10-29 |
20200338194 | CHIMERIC ANTIGEN RECEPTOR (CAR) SIGNALLING SYSTEM | 2020-10-29 |
20200338195 | PHARMACEUTICAL COMPOSITIONS COMPRISING 0.25 MG DOSE OF SYNTHETIC HUMAN PEPTIDES FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS | 2020-10-29 |
20200338196 | WATER-SOLUBLE COMPOUNDS WITH AGGREGATION-INDUCED EMISSION CHARACTERISTICS | 2020-10-29 |
20200338197 | ENGINEERED PRIMATE CYSTINE/CYSTEINE DEGRADING ENZYMES AS ANTINEOGENIC AGENTS | 2020-10-29 |
20200338198 | PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM | 2020-10-29 |
20200338199 | SODIUM CHLORIDE SOLUTION FOR DRUG RECONSTITUTION OR DILUTION | 2020-10-29 |
20200338200 | Stable liquid formulations for pharmaceuticals and supplements | 2020-10-29 |
20200338201 | CONJUGATES AND PREPARATION AND USE THEREOF | 2020-10-29 |